Skip to main content
. 2019 Feb 19;17(4):3842–3850. doi: 10.3892/ol.2019.10052

Figure 1.

Figure 1.

Inhibitory effects of luteolin on the proliferation and invasion of human breast cancer cells. (A) Dose-dependent antitumor effect of luteolin on MDA-MB-231 breast cancer cells after 24 h. Data are presented as the means ± standard deviation (n=3). (B) Luteolin exhibited a significant antitumor effect on the MDA-MB-231 cell line in colony formation assays. (C) Luteolin inhibited cell invasion of MDA-MB-231 cells as detected by a Transwell assay. *P<0.05 vs. the control group (0 µM luteolin); #P<0.05 vs. the 10 µM luteolin group. IC50, half maximal inhibitory concentration.